After rising 120,000 euros in the seed capital round through crowdfunding, Mimetis Biomaterials is looking for partners to join its third round of investment for €2 milion (800,000 euros are covered by a Phase 2 SME Instrument grant).
Mimetis provides the medical sector with a new generation of synthetic bone graft substitutes able to interplay with the host tissue to reach clinical success (MimetikOss). The company located in the Parc Tecnològic del Vallès (Barcelona) is fundraising now to enter the othopaedics market and launch its 3D-printed perzonalised bone regenerative solution.
Enquiries: investors@mimetis.com
If you would like to learn more about Mimetis, we recommend this video interview with CataloniaBio & HealthTech:
Comments